Leptospira IgG/IgM Rapid Test Device (WB/S/P)

Leptospirosis is a bacterial infection caused by Leptospira species. It is commonly associated with exposure to contaminated water, soil, animals, or animal urine. Symptoms may include fever, headache, body pain, chills, red eyes, vomiting, jaundice, and kidney or liver complications in severe cases.

• The Leptospira IgG/IgM Rapid Test Device helps support early screening of suspected leptospirosis.
• Early symptoms of leptospirosis are often non-specific and may resemble dengue, malaria, viral fever, influenza, and other infections.
• IgM antibodies may suggest recent or active immune response, while IgG antibodies may indicate later-stage response, past exposure, or ongoing infection history.
• Rapid antibody screening is useful in hospitals, clinics, public health programs, fever clinics, endemic regions, and professional point-of-care environments.

The Leptospira IgG/IgM Rapid Test Device by LARKSOIS Pharma may be used in professional diagnostic and infectious disease screening environments.

Applications

• Suspected leptospirosis screening
• Fever clinic diagnostic support
• Hospital and laboratory testing
• Endemic-region healthcare programs
• Public health screening support
• Outbreak investigation support
• Travel-related infectious disease evaluation
• Point-of-care diagnostic workflows
• International diagnostic distribution

• The Leptospira IgG/IgM Rapid Test Device works on lateral flow immunochromatographic assay technology.
• When the specimen is added to the test device, it moves across the membrane by capillary action.
• If Leptospira-specific IgG or IgM antibodies are present, they bind with coated antigens and form visible test lines.
• The control line confirms correct sample flow and valid test performance.

The Leptospira IgG/IgM Rapid Test Device uses rapid lateral flow immunochromatographic technology for qualitative detection and differentiation of Leptospira IgG and IgM antibodies in whole blood, serum, or plasma specimens.

Benefits

• Detects Leptospira IgG antibodies
• Detects Leptospira IgM antibodies
• Suitable for whole blood, serum, and plasma
• Rapid visual result
• Simple professional testing workflow
• No complex instrument required
• Supports fever and infectious disease screening
• Useful in endemic-region healthcare settings

The Leptospira IgG/IgM Rapid Test Device supports whole blood, serum, and plasma specimens. This flexibility helps healthcare professionals use the most suitable sample type based on testing workflow and clinical setting.

Guidance

• Use approved whole blood, serum, or plasma specimens only
• Collect specimens according to the product insert
• Use clean and suitable sample collection materials
• Avoid contaminated or improperly stored samples
• Apply the specimen correctly to the test device
• Add buffer according to instructions
• Read results only within the recommended time window
• Handle all specimens according to laboratory safety procedures

Note

Specimen collection, testing, timing, and storage should always follow the official LARKSOIS Pharma kit insert.

The Leptospira IgG/IgM Rapid Test Device by LARKSOIS Pharma is designed for qualitative detection and differentiation of Leptospira IgG and IgM antibodies in whole blood, serum, or plasma specimens. Detection of Leptospira antibodies may support suspected leptospirosis screening and further clinical evaluation.

• An IgM-positive result may indicate recent or active immune response to Leptospira infection.
• An IgG-positive result may suggest past exposure, later-stage immune response, or ongoing infection history.
• Both IgG and IgM positive results may indicate immune response requiring clinical correlation.
• Positive screening results may require confirmatory testing depending on symptoms, exposure history, and healthcare guidelines.

The Leptospira IgG/IgM Rapid Test Device is a professional screening aid and should not be used as the only basis for diagnosis. Results should be interpreted with clinical symptoms, exposure history, and confirmatory testing when required.

Instructions

• For professional in-vitro diagnostic use only
• Use approved specimens only
• Improper specimen handling may affect results
• False positive or false negative results may occur
• Early infection or low antibody levels may affect detection
• Clinical evaluation and confirmatory testing may be required
• Read results only within the recommended time
• Follow the official product insert carefully

Instructions

• Detects Leptospira IgG antibodies
• Detects Leptospira IgM antibodies
• Suitable for whole blood, serum, and plasma
• Rapid visual result
• Simple test procedure
• No complex instrument required
• Supports professional screening programs
• Suitable for international diagnostic supply

Note

The Leptospira IgG/IgM Rapid Test Device by LARKSOIS Pharma is designed for practical, rapid, and accessible leptospirosis antibody screening support.

Steps

• Bring the test device, specimen, and buffer to room temperature
• Open the sealed pouch only when ready to test
• Place the test cassette on a clean and flat surface
• Add whole blood, serum, or plasma to the sample well
• Add buffer according to the instructions for use
• Wait for the recommended reaction time
• Read the IgG, IgM, and control lines within the valid time window
• Do not interpret results after the recommended reading time
• Dispose of used materials according to laboratory safety procedures

Note

Testing should be performed by trained healthcare professionals according to the official LARKSOIS Pharma product insert.

Positive

An IgM-positive result may suggest recent or active immune response. An IgG-positive result may suggest past exposure, later-stage immune response, or ongoing infection history.

Negative

A negative result means Leptospira IgG/IgM antibodies were not detected at the test’s detectable level. Early infection or low antibody levels may still require further testing.

Invalid

If the control line does not appear, the test result is invalid. Testing should be repeated with a fresh device.

Instructions

• Store the Leptospira IgG/IgM Rapid Test Device according to the product label and insert
• Store in a cool and dry place
• Keep sealed until use
• Protect from heat, sunlight, and moisture
• Do not freeze unless specified
• Do not use expired kits
• Use immediately after opening the pouch
• Follow all instructions for use carefully

Instructions

• For professional in-vitro diagnostic use only
• Handle all specimens carefully
• Wear gloves and protective equipment during testing
• Do not reuse the test cassette
• Avoid specimen contamination
• Do not use damaged or expired kits
• Read results only within the recommended time
• Interpret results with clinical findings and exposure history

LARKSOIS Pharma provides internationally suitable diagnostic products for hospitals, laboratories, clinics, healthcare procurement agencies, distributors, and public health programs. The Leptospira IgG/IgM Rapid Test Device is designed for fast, practical, and accessible antibody screening support.

Advantages

• International infectious disease rapid test portfolio
• Reliable Leptospira antibody screening support
• Suitable for hospitals, clinics, and laboratories
• Distributor-friendly product support
• Professional healthcare quality standards
• Practical point-of-care diagnostic format
• Accessible infectious disease screening solution